Literature DB >> 25516914

Dysphoria induced in dialysis providers by secondary hyperparathyroidism.

Irfana H Soomro1, David S Goldfarb2.   

Abstract

Entities:  

Keywords:  calcium; mineral metabolism; phosphate binders

Mesh：

Substances：

Year:  2014        PMID： 25516914      PMCID： PMC4284422          DOI： 10.2215/CJN.11551114

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN： 1555-9041            Impact factor:   8.237


× No keyword cloud information.
  17 in total

1.  Technical and clinical characterization of the Bio-PTH (1-84) immunochemiluminometric assay and comparison with a second-generation assay for parathyroid hormone.

Authors:  Masaaki Inaba; Kiyoshi Nakatsuka; Yasuo Imanishi; Masakazu Watanabe; Yuji Mamiya; Eiji Ishimura; Yoshiki Nishizawa
Journal:  Clin Chem       Date:  2003-12-18       Impact factor: 8.327

2.  Human PTH-(7-84) inhibits bone resorption in vitro via actions independent of the type 1 PTH/PTHrP receptor.

Authors:  P Divieti; M R John; H Jüppner; F R Bringhurst
Journal:  Endocrinology       Date:  2002-01       Impact factor: 4.736

3.  KDOQI US commentary on the 2009 KDIGO Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of CKD-Mineral and Bone Disorder (CKD-MBD).

Authors:  Katrin Uhlig; Jeffrey S Berns; Bryan Kestenbaum; Raj Kumar; Mary B Leonard; Kevin J Martin; Stuart M Sprague; Stanley Goldfarb
Journal:  Am J Kidney Dis       Date:  2010-04-03       Impact factor: 8.860

4.  New worldwide trends in presentation of renal osteodystrophy and its relationship to parathyroid hormone levels.

Authors:  A Gal-Moscovici; M M Popovtzer
Journal:  Clin Nephrol       Date:  2005-04       Impact factor: 0.975

5.  Comparison of intact PTH assay and whole PTH assay in long-term dialysis patients.

Authors:  S Nakanishi; J J Kazama; T Shigematsu; Y Iwasaki; T L Cantor; T Kurosawa; M Fukagawa
Journal:  Am J Kidney Dis       Date:  2001-10       Impact factor: 8.860

6.  A novel mechanism for skeletal resistance in uremia.

Authors:  E Slatopolsky; J Finch; P Clay; D Martin; G Sicard; G Singer; P Gao; T Cantor; A Dusso
Journal:  Kidney Int       Date:  2000-08       Impact factor: 10.612

7.  KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD).

Authors: 
Journal:  Kidney Int Suppl       Date:  2009-08       Impact factor: 10.545

8.  Longitudinal HR-pQCT and image registration detects endocortical bone loss in kidney transplantation patients.

Authors:  Kyle K Nishiyama; Yves Pauchard; Lucas E Nikkel; Sapna Iyer; Chiyuan Zhang; Donald J McMahon; David Cohen; Steven K Boyd; Elizabeth Shane; Thomas L Nickolas
Journal:  J Bone Miner Res       Date:  2015-03       Impact factor: 6.741

9.  Mortality risk for dialysis patients with different levels of serum calcium, phosphorus, and PTH: the Dialysis Outcomes and Practice Patterns Study (DOPPS).

Authors:  Francesca Tentori; Margaret J Blayney; Justin M Albert; Brenda W Gillespie; Peter G Kerr; Jürgen Bommer; Eric W Young; Tadao Akizawa; Takashi Akiba; Ronald L Pisoni; Bruce M Robinson; Friedrich K Port
Journal:  Am J Kidney Dis       Date:  2008-06-02       Impact factor: 8.860

10.  Vitamin D levels and early mortality among incident hemodialysis patients.

Authors:  M Wolf; A Shah; O Gutierrez; E Ankers; M Monroy; H Tamez; D Steele; Y Chang; C A Camargo; M Tonelli; R Thadhani
Journal:  Kidney Int       Date:  2007-08-08       Impact factor: 10.612
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.